Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, Inc.

51 F. Supp. 2d 302, 1999 U.S. Dist. LEXIS 8090, 1999 WL 350887
CourtDistrict Court, S.D. New York
DecidedJune 1, 1999
Docket97 CIV. 3403 RO, 97 CIV. 8357 RO
StatusPublished
Cited by5 cases

This text of 51 F. Supp. 2d 302 (Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, Inc., 51 F. Supp. 2d 302, 1999 U.S. Dist. LEXIS 8090, 1999 WL 350887 (S.D.N.Y. 1999).

Opinion

MEMORANDUM AND ORDER

OWEN, District Judge.

I presided over the trial here that lasted four days in April 1998. I found that the defendants willfully infringed the plaintiffs’ patent for famotidine in violation of the Hatch-Waxman Act, Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, Inc., 21 F.Supp.2d 366, 378 (S.D.N.Y.1998), familiarity with which is assumed. I found that this case constituted an “exceptional case” within the meaning of Section 285, and on that basis awarded attorneys’ fees to the plaintiffs, in an amount to be determined. The parties have since submitted post-trial declarations and briefs on this issue.

Central here is the reasonableness of the plaintiffs’ request. The starting point in determining a fee award is arriving at the lodestar amount — that is, multiplying the reasonable hours spent by a reasonable billing rate. Blanchard v. Bergeron, 489 U.S. 87, 94, 109 S.Ct. 939, 103 L.Ed.2d 67 (1989). Reasonable rates are those “normally charged for similar work by attorneys of like skill in the area.” New York State Assoc., for Retarded Children, Inc. v. Carey, 711 F.2d 1136, 1140 (2nd Cir.1983). Reasonable hours are those which are “1) thoroughly documented; 2) spent upon the issues which gave rise to the finding of exceptional circumstances; 3) non-duplicative; and 4) not spent in a manner inconsistent with a standard of reasonable efficiency and productivity.” Codex Cory. v. Milgo Electronic Corp., 541 F.Supp. 1198, 1203 (D.Mass.1982) (citations omitted).

As to reasonableness, the defendants assert several objections, which I address in the order presented.

First, the defendants claim that the billing rates charged by plaintiffs’ attorneys are too high. In determining a reasonable rate, the court may refer to American Intellectual Property Law Association (AIPLA) surveys. See Mathis v. Spears, 857 F.2d 749, 755 (Fed.Cir.1988). 1 I do so, *305 noting, however, that the AIPLA survey’s high mark represents the hourly billing rate of the 75th percentile of attorneys reporting, which means that 25 percent of attorneys actually reported above that figure. Moreover, notwithstanding the AI-PLA survey, some consideration may be given to the experience,' reputation and ability of the attorneys, as well as to the difficulty of the issues presented and the amount at stake in the litigation. See Hensley v. Eckerhart, 461 U.S. 424, 429-30, n. 3, 103 S.Ct. 1933, 76 L.Ed.2d 40 (1983) (citing the twelve factors listed in Johnson v. Georgia Highway Express, 488 F.2d 714, 717 (5th Cir.1974)); Howes v. Medical Components, Inc., 761 F.Supp. 1193, 1195-97 (E.D.Pa.1990) (upward departure from AIPLA survey for intellectual property law practitioners because “a party should be entitled to retain the most competent counsel available, particularly in the highly specialized area of complex patent litigation,” and plaintiffs’ fees were comparable to those of other New York .City firms which handle complex litigation); Stryker Corp. v. Intermedies Orthopedics, Inc., 898 F.Supp. 116, 125 (E.D.N.Y.1995) (downward departure from AIPLA “based on the type of work performed and the experience of the attorneys”).

Yamanouchi’s various counsel were highly experienced! The AIPLA guidelines set the rate at $225 to $300 for partners with experience in intellectual property law. However, plaintiffs submitted surveys conducted by Aspen Law & Business in 1998, by the National Law Journal in 1996, both of which indicate that partners in some of the prominent law . firms in New York City charge between $400 and $475 per hour. Each of these surveys include at least one firm which specializes in patent litigation, and the rates listed for those firms are comparable with the others. Thus, although many of the plaintiffs’ attorneys billed above the AIPLA rate, 2 I find that the hourly rates were ball-park reasonable for New York City. 3

As to paralegals, the defendants rely on case law for a rate of $50 per hour. 4 Plaintiffs used paralegals from within the law firm as well as from temporary employment agencies. Those from temp agencies billed $23 to $30' per hour, while those from within the law firm were billed at $70 to $95 per hour. With such a range of rates charged, I conclude that the average rate charged is comparable to other paralegals’ working on this type of litigation. I do agree with defendants' that plaintiffs may not charge a paralegal rate when the paralegal is performing only clerical tasks. Missouri v. Jenkins, 491 U.S. 274, 288 n. 10, 109 S.Ct. 2463, 105 L.Ed.2d 229 (1989). Plaintiffs note that their paralegals' performed numerous tasks, including organizing the case file, preparing materials for attorneys, and keeping track of discovery documents. Since plaintiffs’ time records list the attorney or paralegal by their initials, not their full name, it is not reasonable for this *306 court to look through the submissions to find what tasks each paralegal was performing. While perhaps there may have been some billing for clerical tasks such as “putting documents into boxes,” that should have been billed at lower rate, I do not see any specific evidence that the use of paralegals by Yamanouehi and Merck was essentially unreasonable in other ways. Some adjustment hereafter may deal with these uncertainties.

The defendants next contend that the plaintiffs over-staffed the case. First, they contend that Merck did not need to hire separate attorneys since Yamanouehi and Merck had the exact same interest in the litigation, that is, that the patent be found valid (which it was). 5 I disagree. Merck’s attorneys performed most of the discovery tasks, which were significant in this case. Second, defendants argue that both Yamanouehi and Merck employed too many attorneys. Nine attorneys are listed in Yamanouehi’s submissions, but four of those nine spent less than three hours each on the case. Counsel for Merck did not submit summaries of their billing in a way that facilitates an analysis of their staffing. However, the defendants’ implication that this case was a simple one has no merit, and given the time constraints imposed on plaintiffs to prepare their case, as well as the complexity of the issues and the stakes involved, I cannot with confidence say that plaintiffs staffing was unreasonable. I do question why it was necessary to have two Merck attorneys present at trial, in addition to the five Yamanouehi attorneys.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Enron Corp. Securities
586 F. Supp. 2d 732 (S.D. Texas, 2008)
Eli Lilly & Co. v. Zenith Goldline Pharmaceuticals, Inc.
264 F. Supp. 2d 753 (S.D. Indiana, 2003)
Rambus, Inc. v. Infineon Technologies AG
155 F. Supp. 2d 668 (E.D. Virginia, 2001)
Ulead Systems, Inc. v. Lex Computer & Management Corp.
151 F. Supp. 2d 1192 (C.D. California, 2001)
Yurman Designs, Inc. v. PAJ, INC.
125 F. Supp. 2d 54 (S.D. New York, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
51 F. Supp. 2d 302, 1999 U.S. Dist. LEXIS 8090, 1999 WL 350887, Counsel Stack Legal Research, https://law.counselstack.com/opinion/yamanouchi-pharmaceutical-co-v-danbury-pharmacal-inc-nysd-1999.